DGAT1 protects tumor from lipotoxicity, emerging as a promising metabolic target for cancer therapy

Area of Science:

• Oncology
• Cancer Biology
• Biochemistry

Background:

• Glioblastoma is the deadliest form of brain cancer.
• Cancer cells often alter metabolic pathways to support rapid growth.
• Fatty acid metabolism plays a critical role in cancer cell survival and proliferation.

Purpose of the Study:

• To investigate the role of diacylglycerol O-acyltransferase 1 (DGAT1) in glioblastoma.
• To determine if targeting DGAT1 can be a viable therapeutic strategy for glioblastoma.

Main Methods:

• Analysis of DGAT1 expression in glioblastoma samples.
• Inhibition of DGAT1 in glioblastoma cell models.
• Assessment of cell death and oxidative stress markers following DGAT1 inhibition.

Main Results:

• Glioblastoma significantly upregulates DGAT1 to manage excess fatty acids.
• DGAT1 upregulation facilitates triglyceride synthesis, preventing lipotoxicity and promoting tumor growth.
• Targeting DGAT1 led to substantial glioblastoma cell death.

Conclusions:

• DGAT1 plays a crucial role in glioblastoma pathogenesis by regulating fatty acid storage.
• Inhibition of DGAT1 induces significant oxidative stress and cell death in glioblastoma.
• DGAT1 represents a promising therapeutic target for glioblastoma treatment.